Impetigo

2

Review clinical trials related to Impetigo. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Comparative Study of Adherence to Antibiotic Therapy Among Pediatric Patients: Hospital Emergency Department vs. Primary Care Center

This study was initiated because of the limited litterature available on this topic. The objective was to compare adherence to antibiotic therapy among a pediatric population treated in two healthcare settings in France: the Gignac Health Center, a primary care facility, and the Pediatric Emergency Department of Montpellier University Hospital. This observational study assessed treatment adherence through a telephone questionnaire administered to parents after the theorical end of the treatment.

Participants needed: 191
Trial details
Age: 3-16Biological sex: AllType: ObservationalSponsor: University Hospital, MontpellierUpdated: Jul 17, 2026
Eligibility criteria

Children aged 3 months to 16 years [+2]

Unemancipated minors presenting without a parent or legal guardian. [+5]

Status: Recruiting

Perspectives on Antibiotics and Tracking Symptoms in Children

The study will assess families' perspectives and decision-making regarding the duration of oral antibiotic courses prescribed to children (4-17 years) who present with uncomplicated bacterial infections at the Royal Children's Hospital (RCH) Emergency Department (ED). The study will involve (i) children discharged from ED on oral antibiotics and (ii) children transferred to Hospital-in-the-Home (HITH) on IV antibiotics who then switch to oral antibiotics. In addition, the study will assess how feasible and acceptable it is to track children's symptoms via the Garmin Smartwatch and the WeGuide platform (WeGuide is a patient engagement software platform that allows for enrolment, consent, and data collection \[via questionnaires/surveys and from the Garmin Smartwatches\] through a singular platform).

Participants needed: 300
Trial details
Age: 4-17Biological sex: AllType: InterventionalSponsor: Murdoch Childrens Research InstituteUpdated: Sep 22, 2025Locations: 1
Eligibility criteria

Between the ages of ≥ 4 years and ≤ 17 years at enrolment. [+3]